NCT05934331 2025-09-12A LM-302 Combination With Other Anti-Tumor Therapies Phase ll StudyLaNova Medicines LimitedPhase 2 Recruiting276 enrolled
NCT04415853 2025-05-18Study of Larotinib in Unresectable Advanced or Recurrent Esophageal CancerSunshine Lake Pharma Co., Ltd.Phase 3 Recruiting416 enrolled